Structure Therapeutics' Obesity Drug Success
This is a Zepbound news story, published by Yahoo News Canada, that relates primarily to Structure news.
Zepbound news
For more Zepbound news, you can click here:
more Zepbound newsStructure news
For more Structure news, you can click here:
more Structure newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo News Canada news
For more news from Yahoo News Canada, you can click here:
more news from Yahoo News CanadaAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
oral weight loss drug orforglipron. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest loss drug Wegovy news, new tablet formulation news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
experimental oral obesity drugReuters
•Structure's obesity drug reduces more weight than expected in study
77% Informative
Structure Therapeutics' GSBR-1290 helped reduce weight by 6.2% on average in a mid-stage study.
The drug's once-daily oral drug is similar to Novo Nordisk's Wegovy and Eli Lilly's Zepbound .
Structure 's shares were 20% higher in premarket trading.
VR Score
89
Informative language
98
Neutral language
9
Article tone
formal
Language
English
Language complexity
47
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links